UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 48

Sortiert nach

Annexin A2 and cancer: A systematic review

International journal of oncology, 2018-01, Vol.52 (1), p.5-18

2018

Volltextzugriff (PDF)

Evaluation of HE4, CA125, risk of ovarian malignancy algorithm (ROMA) and risk of malignancy index (RMI) as diagnostic tools of epithelial ovarian cancer in patients with a pelvic mass

Gynecologic oncology, 2012-11, Vol.127 (2), p.379-383

2012

Volltextzugriff (PDF)

A novel diagnostic index combining HE4, CA125 and age may improve triage of women with suspected ovarian cancer — An international multicenter study in women with an ovarian mass

Gynecologic oncology, 2015-09, Vol.138 (3), p.640-646

2015

Volltextzugriff (PDF)

A novel proteomic biomarker panel as a diagnostic tool for patients with ovarian cancer

Gynecologic oncology, 2011-11, Vol.123 (2), p.308-313

2011

Volltextzugriff (PDF)

Should CA-125 Response Criteria Be Preferred to Response Evaluation Criteria in Solid Tumors (RECIST) for Prognostication During Second-Line Chemotherapy of Ovarian Carcinoma?

Journal of clinical oncology, 2004-10, Vol.22 (20), p.4051-4058

2004

Volltextzugriff (PDF)

HE4 tissue expression and serum HE4 levels in healthy individuals and patients with benign or malignant tumors: a systematic review

Cancer epidemiology, biomarkers & prevention, 2014-11, Vol.23 (11), p.2285-2295

2014

Volltextzugriff (PDF)

Distribution of p53 expression in tissue from 774 Danish ovarian tumour patients and its prognostic significance in ovarian carcinomas

APMIS : acta pathologica, microbiologica et immunologica Scandinavica, 2008-05, Vol.116 (5), p.400-409

2008

Volltextzugriff (PDF)

Are we ready for translational research based on material and data from the Danish CancerBiobank and can we gain new knowledge from biobank registration?

APMIS : acta pathologica, microbiologica et immunologica Scandinavica, 2023-10, Vol.131 (10), p.536-542

2023

Volltextzugriff (PDF)

Limited prognostic value of tissue protein expression levels of BCl-2 in Danish ovarian cancer patients: from the Danish 'MALOVA' ovarian cancer study

APMIS : acta pathologica, microbiologica et immunologica Scandinavica, 2010-08, Vol.118 (8), p.557-564

2010

Volltextzugriff (PDF)

Association of CD31 and p53 With Survival of Ovarian Cancer Patients

Anticancer research, 2019-02, Vol.39 (2), p.567-576

2019

Volltextzugriff (PDF)

K- ras alterations in Danish ovarian tumour patients. : From the danish “malova” ovarian cancer study

Gynecologic oncology, 2003-04, Vol.89 (1), p.31-36

2003

Volltextzugriff (PDF)

Tissue microRNAs as predictors of outcome in patients with metastatic colorectal cancer treated with first line Capecitabine and Oxaliplatin with or without Bevacizumab

PloS one, 2014-10, Vol.9 (10), p.e109430

2014

Volltextzugriff (PDF)

CA125 expression pattern, prognosis and correlation with serum CA125 in ovarian tumor patients

Gynecologic oncology, 2007, Vol.104 (3), p.508-515

2007

Volltextzugriff (PDF)

P53 mutations in tissue from Danish ovarian cancer patients

Gynecologic oncology, 2006, Vol.100 (1), p.76-82

2006

Volltextzugriff (PDF)

YKL-40 tissue expression and plasma levels in patients with ovarian cancer

BMC cancer, 2009-01, Vol.9 (1), p.8-8, Article 8

2009

Volltextzugriff (PDF)

Risk of malignancy index used as a diagnostic tool in a tertiary centre for patients with a pelvic mass

Acta obstetricia et gynecologica Scandinavica, 2012-04, Vol.91 (4), p.496-502

2012

Volltextzugriff (PDF)

CA125 expression pattern, prognosis and correlation with serum CA125 in ovarian tumor patients. From The Danish "MALOVA" Ovarian Cancer Study

Gynecologic oncology, 2007-03, Vol.104 (3), p.508-515

2007

Volltextzugriff (PDF)

Prognostic value of estrogen receptor and progesterone receptor tumor expression in Danish ovarian cancer patients : From the 'MALOVA' Ovarian Cancer Study

Oncology reports, 2007-11, Vol.18 (5), p.1051-1059

2007

Volltextzugriff (PDF)

Serum YKL-40 and gestational diabetes - an observational cohort study

APMIS : acta pathologica, microbiologica et immunologica Scandinavica, 2016-09, Vol.124 (9), p.770-775

2016

Volltextzugriff (PDF)

Distribution of HER-2 overexpression in ovarian carcinoma tissue and its prognostic value in patients with ovarian carcinoma: From the Danish MALOVA Ovarian Cancer Study

Cancer, 2003-07, Vol.98 (1), p.66-73

2003

Volltextzugriff (PDF)

Tetranectin positive expression in tumour tissue leads to longer survival in Danish women with ovarian cancer. Results from the 'Malova' ovarian cancer study

APMIS : acta pathologica, microbiologica et immunologica Scandinavica, 2015-05, Vol.123 (5), p.401-409

2015

Volltextzugriff (PDF)

CT versus FDG‐PET/CT response evaluation in patients with metastatic colorectal cancer treated with irinotecan and cetuximab

Cancer medicine (Malden, MA), 2014-10, Vol.3 (5), p.1294-1301

2014

Volltextzugriff (PDF)

Prognostic value of tissue protein expression levels of MIB-1 (Ki-67) in Danish ovarian cancer patients. From the 'MALOVA' ovarian cancer study

APMIS : acta pathologica, microbiologica et immunologica Scandinavica, 2013-12, Vol.121 (12), p.1177-1186

2013

Volltextzugriff (PDF)

Alpha-fetoprotein in human fetal cerebrospinal fluid

Clinica chimica acta, 2000-01, Vol.291 (1), p.35-41

2000

Volltextzugriff (PDF)

Association of Reproductive Factors, Oral Contraceptive Use and Selected Lifestyle Factors with the Risk of Ovarian Borderline Tumors: A Danish Case-Control Study

Cancer causes & control, 2006-08, Vol.17 (6), p.821-829

2006

Volltextzugriff (PDF)

1 – 25 von 48

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(45)
Mit Volltextzugriff
(43)

Publikationsform

Artikel
(48)

Sprache

Englisch
(48)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Annexin A2 and cancer: A systematic review

Evaluation of HE4, CA125, risk of ovarian malignancy algorithm (ROMA) and risk of malignancy index (RMI) as diagnostic tools of epithelial ovarian cancer in patients with a pelvic mass

A novel diagnostic index combining HE4, CA125 and age may improve triage of women with suspected ovarian cancer — An international multicenter study in women with an ovarian mass

A novel proteomic biomarker panel as a diagnostic tool for patients with ovarian cancer

Should CA-125 Response Criteria Be Preferred to Response Evaluation Criteria in Solid Tumors (RECIST) for Prognostication During Second-Line Chemotherapy of Ovarian Carcinoma?

HE4 tissue expression and serum HE4 levels in healthy individuals and patients with benign or malignant tumors: a systematic review

Distribution of p53 expression in tissue from 774 Danish ovarian tumour patients and its prognostic significance in ovarian carcinomas

Are we ready for translational research based on material and data from the Danish CancerBiobank and can we gain new knowledge from biobank registration?

Limited prognostic value of tissue protein expression levels of BCl-2 in Danish ovarian cancer patients: from the Danish 'MALOVA' ovarian cancer study

Association of CD31 and p53 With Survival of Ovarian Cancer Patients

K- ras alterations in Danish ovarian tumour patients. : From the danish “malova” ovarian cancer study

Tissue microRNAs as predictors of outcome in patients with metastatic colorectal cancer treated with first line Capecitabine and Oxaliplatin with or without Bevacizumab

CA125 expression pattern, prognosis and correlation with serum CA125 in ovarian tumor patients

P53 mutations in tissue from Danish ovarian cancer patients

YKL-40 tissue expression and plasma levels in patients with ovarian cancer

Risk of malignancy index used as a diagnostic tool in a tertiary centre for patients with a pelvic mass

CA125 expression pattern, prognosis and correlation with serum CA125 in ovarian tumor patients. From The Danish "MALOVA" Ovarian Cancer Study

Prognostic value of estrogen receptor and progesterone receptor tumor expression in Danish ovarian cancer patients : From the 'MALOVA' Ovarian Cancer Study

Serum YKL-40 and gestational diabetes - an observational cohort study

Distribution of HER-2 overexpression in ovarian carcinoma tissue and its prognostic value in patients with ovarian carcinoma: From the Danish MALOVA Ovarian Cancer Study

Tetranectin positive expression in tumour tissue leads to longer survival in Danish women with ovarian cancer. Results from the 'Malova' ovarian cancer study

CT versus FDG‐PET/CT response evaluation in patients with metastatic colorectal cancer treated with irinotecan and cetuximab

Prognostic value of tissue protein expression levels of MIB-1 (Ki-67) in Danish ovarian cancer patients. From the 'MALOVA' ovarian cancer study

Alpha-fetoprotein in human fetal cerebrospinal fluid

Association of Reproductive Factors, Oral Contraceptive Use and Selected Lifestyle Factors with the Risk of Ovarian Borderline Tumors: A Danish Case-Control Study

Suchergebnisse filtern